Parabolic Drugs obtains European GMP certification

Parabolic Drugs (PDL) has started its commercial operations in 1998 with contract manufacturing of APIs and API intermediates for sales in India and abroad (including regulated markets). At present, Parabolic Drugs has four facilities consisting of three manufacturing plants i.e. Derabassi, Chachrauli (both Punjab) and Panchkula and a Research & Development centre at Barwala (both Haryana).